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A Novel Function for SMN, the Spinal Muscular
Atrophy Disease Gene Product,
in Pre-mRNA Splicing
(Liu and Dreyfuss, 1996). The SMN protein is tightly
associated with another protein, called SIP1, which has
a similar cellular localization and tissue distribution to
that of SMN (Liu et al., 1997). Previous studies on SMN
and SIP1 demonstrated that they are present in a com-
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Philadelphia, Pennsylvania 19104-6148 plex that contains additional proteins, including some
of the Sm proteins that are common components of
spliceosomal snRNPs. The presence of Sm proteins in
the SMN- and SIP1-containing complex is a result of aSummary
direct interaction between SMN and several of the Sm
proteins (Liu et al., 1997). Antibody microinjection exper-Spinal muscular atrophy (SMA) is a common motor
iments in Xenopus laevis oocytes revealed that SIP1 hasneuron degenerative disease that results from re-
a critical role in the assembly of snRNPs (Fischer et al.,duced levels of, or mutations in, the Survival of Motor
1997; reviewed in Mattaj, 1998), a process that takesNeurons (SMN) protein. SMN is found in the cytoplasm
place in the cytoplasm, where the Sm proteins combineand the nucleus where it is concentrated in gems. SMN
with the snRNAs that are exported from the nucleusinteracts with spliceosomal snRNP proteins and is
(Mattaj and De Robertis, 1985; Mattaj, 1988; Luhrmanncritical for snRNP assembly in the cytoplasm. We show
et al., 1990). This assembled snRNP, which is subse-that a dominant-negative mutant SMN (SMNDN27)
quently modified further, then recruits the necessarycauses a dramatic reorganization of snRNPs in the
nuclear import receptors and is translocated to the nu-nucleus. Furthermore, SMNDN27 inhibits pre-mRNA
cleus where the snRNPs function in pre-mRNA splicingsplicing in vitro, while wild-type SMN stimulates splic-
(Mattaj, 1986, 1988; Luhrmann et al., 1990; Neuman deing. SMN mutants found in SMA patients cannot stimu-
Vegvar and Dahlberg, 1990; Zieve and Sauterer, 1990).late splicing. These findings demonstrate that SMN
A role for SMN in snRNP assembly could be inferred fromplays a crucial role in the generation of the pre-mRNA
the effects of anti-SIP1 antibodies and the presence ofsplicing machinery and thus in mRNA biogenesis, and
SMN in the same complexes, and from the effect ofthey link the function of SMN in this pathway to SMA.
the anti-SMN antibodies on this process. However, in
contrast to the inhibitory effect of anti-SIP1 antibodies,
Introduction the anti-SMN antibodies have shown some stimulation
of snRNP assembly (Fischer et al., 1997). These experi-
Spinal muscular atrophy (SMA) is a common human ments left open several important questions that we
genetic disease that is the leading hereditary cause of sought to address further. First, is SMN also directly
infant mortality (Roberts et al., 1970; Pearn, 1973, 1978; involved in snRNP assembly? Second, is this an oocyte-
Czeizel and Hamula, 1989). SMA is a motor neuron de- specific phenomenon, or do SMN and SIP1 have a role
generative disease that results from deletions or muta- in snRNP biogenesis in all cells? And third, what might
tions in the Survival of Motor Neurons (SMN) gene, which be the function of the nuclear pool of SMN and SIP1,
is duplicated as an inverted repeat on human chromo- and by extension, what is the function of gems?
some 5 at 5q13 (Brzustowicz et al., 1990; Melki et al., Here we have carried out experiments in somatic cells
1990; Lefebvre et al., 1995). The telomeric copy of the to address these questions and to further characterize
SMN gene is deleted or mutated in over 98% of SMA the function of the SMN protein. We have utilized a
patients (Bussaglia et al., 1995; Chang et al., 1995; Cob- mutant of SMN that we generated as part of our studies
ben et al., 1995; Hahnen et al., 1995, 1996; Lefebvre et on the functional domains of SMN. Using a mutant that
al., 1995; Rodrigues et al., 1995; Velasco et al., 1996). The lacks the first amino-terminal 27 amino acids, SMNDN27,
SMN protein is expressed in all tissues of mammalian we found that this protein has a dominant-negative phe-
organisms, but particularly high levels are expressed in notype on snRNP biogenesis and function. The studies
motor neurons (Coovert et al., 1997; Lefebvre et al., we report here demonstrate that SMN is critical for
1997). In contrast, in individuals affected by the most spliceosomal snRNP assembly in the cytoplasm of so-
severe form of SMA, Werdnig-Hoffman syndrome or matic cells and, importantly, they reveal novel functions
SMA type I, the SMN protein is barely detectable in for SMN in the nucleus. Based on both in vivo and in
motor neurons (Coovert et al., 1997; Lefebvre et al., vitro experiments, we show that SMN is required for
1997). The SMN protein is a 40 kDa polypeptide with no pre-mRNA splicing, probably for the regeneration or re-
recognizable sequence motifs that is found both in the cycling of snRNPs and possibly other splicing factors.
nucleus and in the cytoplasm. In the nucleus, SMN is Mutant SMNs, such as those that are found in SMA
concentrated in bodies called gems, similar in size and patients, lack the splicing±regenerating activity of wild-
number to coiled bodies and often associated with them type SMN. We conclude that SMN plays a crucial role
in the biogenesis of mRNA, and that deficiencies in this
activity of SMN are, at least in part, the molecular cause* To whom correspondence should be addressed (e-mail: gdreyfuss
@hhmi.upenn.edu). of SMA.
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Figure 1. Redistribution of Sm Proteins in
Cells Expressing the SMNDN27 Mutant
Double-label confocal immunofluorescence
experiments using the anti-myc tag mono-
clonal antibody 9E10 (green) and the anti-Sm
monoclonal antibody Y12 (red) on HeLa cells
transiently transfected with myc-SMNwt (A±C)
and myc-SMNDN27 (D±F). The respective com-
bined images are shown in (C) and (F); colo-
calization results in a yellow signal. The nuclear
gems (C) and the cytoplasmic accumulations
(F) are indicated by arrows; the dashed line
demarcates the nucleus.
Results SMNDN27 and with snRNPs (data not shown). The num-
ber of the merged SMN- and snRNP-containing bodies
in the SMNDN27-transfected cells is greater than theA Dominant-Negative SMN Mutant Causes
Reorganization of snRNPs, Gems, number of gems (or of coiled bodies) in control cells,
and they are much larger than gems and coiled bodies.and Coiled Bodies
To define the functional domains of SMN, we con- These merged structures can become as large as the
nucleoli.structed various deletion mutants and studied their in-
teractions with SIP1 and the Sm proteins in vitro by We further examined the localization of a specific
spliceosomal snRNA in cells transfected with SMNDN27.binding assays, and in vivo by coimmunoprecipitation
after transfections into mammalian cells. As part of these To do so, we determined the localization of U2 snRNA by
in situ hybridization with a U2-specific antisense probeexperiments, we monitored the expression and cellular
localization of the myc-tagged mutants as well as their (Matera and Ward, 1993). Figure 2 shows that the cyto-
plasmic accumulations that intensely stain for both theeffect on snRNP localization. A complete account of
the domain mapping of SMN and SIP1 will be reported SMNDN27 and Sm proteins also contain U2 snRNA,
while cells transfected with wild-type SMN show onlyelsewhere (L. Pellizzoni et al., unpublished data). A par-
ticularly striking effect was observed by transfection of slight cytoplasmic background staining (data not shown).
This suggests that complexes containing Sm proteins,amino terminal deletion mutants, and one of these, a
mutant lacking the first 27 amino acids of SMN, SMND snRNAs, and SMN accumulate in the cytoplasm, likely
representing a block in the pathway of cytoplasmicN27, has been investigated in detail. Double-label immu-
nofluorescence using anti-myc-tag antibodies to detect snRNP assembly. This block could be further pinpointed
by immunostaining with an anti-trimethyl-G cap (TMG)-either the transfected myc-SMN or myc-SMNDN27, and
the anti-Sm antibody Y12 showed accumulation in the specific antibody. The TMG cap is formed by hyper-
methylation of the 59 mono-methyl-G cap of the snRNAs,cytoplasm of Sm proteins colocalized with the mutant
SMNDN27 in discrete aggregates (Figure 1). In the nu- and this step has been shown to take place in the cyto-
plasm after Sm core assembly has occurred (Mattaj,cleus, a striking rearrangement of snRNPs was observed
and they also colocalized with SMNDN27. In contrast, 1986; Fischer and Luhrmann, 1990). The staining indi-
cates that although the cytoplasmic accumulationsin cells transfected with wild-type myc-tagged SMN
(Figure 1A and 1C), as in untransfected cells, there is a caused by SMNDN27 contain U2 as well as Sm proteins
and SMN, the snRNAs within them do not receive thebarely detectable signal of Sm proteins in the cytoplasm,
and the nuclear staining of Sm snRNPs shows general TMG modification (Figure 2D and 2F). Although we can-
not exclude the possibility that the lack of TMG stainingnucleoplasmic distribution with higher local concentra-
tions in interchromatin granules (also referred to as in the cytoplasm is a result of masking, the complete
absence of signal and the strong staining in the nucleusªspecklesº), and particularly intense staining in coiled
bodies (Carmo-Fonseca et al., 1991; Huang and Spector, make this unlikely. Thus, we conclude that the snRNP
assembly pathway in the cytoplasm is arrested at a step1992). In these cells, SMN staining of gems is visible
adjacent to and in most cases overlapping with that of preceding the cap hypermethylation. The snRNAs in the
nuclei of the same cells, however, are hypermethylated,coiled bodies (Figure 1C, and see below). There is a
higher diffuse nucleoplasmic staining of myc-SMN than since they stain efficiently with the anti-TMG antibody.
These effects of SMNDN27 suggest that it has a domi-is normally seen in untransfected cells likely due to the
overexpression of the protein, but the size, number, and nant-negative phenotype over wild-type SMN. They also
suggest that SMN and SIP1 interact with Sm proteinslocalization of gems is unchanged relative to untrans-
fected cells. In the SMNDN27-transfected cells, endoge- in the cytoplasm and, importantly, also with snRNPs
in the nucleus. Furthermore, these findings show thatnous SMN and SIP1 are completely colocalized with
Spinal Muscular Atrophy and Pre-mRNA Splicing
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Figure 2. Redistribution of U snRNAs in Cells
Expressing the SMNDN27 Mutant
(A±C) Double-label confocal immunofluores-
cence experiments using the anti-myc tag
monoclonal antibody 9E10 (A) and in situ hy-
bridization showing U2 snRNA localization
with a U2-specific antisense oligo probe (B).
(D±F) Double-label confocal immunofluores-
cence experiments using an anti-myc tag
rabbit affinity-purified polyclonal antibody
against the 9E10 epitope (D) and the anti-
TMG cap monoclonal antibody K121 (E). The
respective combined images are shown in (C)
and (F); colocalization results in a yellow sig-
nal. The cytoplasmic accumulations are indi-
cated by arrows; the dashed line demarcates
the nucleus.
mutations in SMN can have profound effects on both containing aggregates that are similar in appearance to
those observed in cells in which snRNPs are inactivatedthe biogenesis and localization of spliceosomal snRNPs
in the cell. by antisense oligonucleotides (O'Keefe et al., 1994) or
when transcription is inhibited by actinomycin D (ZengGems, the structures in which SMN and SIP1 are most
highly concentrated in the nucleus, are usually found et al., 1997), suggested that SMNDN27 may cause an
inactivation of snRNPs and possibly of other pre-mRNAadjacent to and very often merged with coiled bodies
(Liu and Dreyfuss, 1996; Liu et al., 1997). We therefore splicing factors. To address this directly, we studied the
effect of SMNDN27 on pre-mRNA splicing in an in vitroasked whether the SMN mutant, SMNDN27, has any
effect on the structure or organization of coiled bodies system. SMNwt and SMNDN27 were produced in bacte-
ria as recombinant proteins bearing a his-tag, purifiedby staining the cells with antibodies to p80 coilin, a
coiled bodies-specific marker (Andrade et al., 1991). The to homogeneity, and added to nuclear splicing extracts.
The 32P-labeled chicken d-crystallin pre-mRNA was usedimmunomicrographs show that coiled bodies and gems
become completely merged in the nucleus and that the as a splicing probe and the reaction products were ana-
p80 coilin staining completely coincides with the stain- lyzed by gel electrophoresis. Addition of SMNwt or the
ing of the enlarged gems (Figure 3). These enlarged SMNDN27 mutant to the reaction at time zero had almost
merged nuclear structures therefore contain snRNPs, no effect on the splicing reaction, although they appear
coiled bodies, and gem components. The reorganization to stabilize the intron (Figure 4A). We then considered
of coiled bodies that SMNDN27 brings about suggests a the possibility that while SMN might not be a splicing
functional relationship between SMN and coiled bodies. factor per se, it may be important for some function akin
to its role in snRNP assembly in the cytoplasm, namely
that although nuclear snRNPs are thought to be stableSMNDN27 Inhibits pre-mRNA Splicing When
Added during Preincubation and fully assembled, they may need to be regenerated
or reassembled between rounds of splicing, and thatThe profound effect of SMN on the organization of nu-
clear snRNPs, particularly the formation of large snRNP- SMN may be required for this process. To address this
Figure 3. Redistribution of p80 Coilin in Cells
Expressing the SMNDN27 Mutant
Double-label confocal immunofluorescence
experiments using the anti-myc tag mono-
clonal antibody 9E10 (green) and the anti-p80
coilin rabbit polyserum R288 (red) on HeLa
cells transiently transfected with myc-SMN
wt (A±C) and myc-SMNDN27 (D±F). The re-
spective combined images are shown in (C)
and (F); colocalization results in a yellow sig-
nal. The nuclear gems (C) and the cyto-
plasmic accumulations (F) are indicated by
arrows; the dashed line demarcates the nu-
cleus.
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Figure 5. The Effect of SMN Recombinant Proteins on Spliceosome
Formation In Vitro
Splicing reactions were carried out using a-32P-labeled chicken
d-crystallin pre-mRNA without (lanes 1 and 2) or with (lanes 3±5)
preincubation. Splicing complexes were fractionated by electropho-
resis on a native polyacrylamide gel and visualized by autoradiog-Figure 4. Effect of SMN Wild-Type and SMNDN27 Recombinant
raphy.Proteins on pre-mRNA Splicing In Vitro
(A) In vitro splicing assays in the presence of SMN wild-type and
SMNDN27 recombinant proteins. a-32P-labeled chicken d-crystallin SMNDN27 Blocks the Formation of Spliceosomalpre-mRNA was incubated for 20 or 40 min at 308C with 50 mg of
Complex C and SMNwt Stimulates SpliceosomeHeLa cell nuclear extracts (13 mg/ml) in the presence of buffer D
Formation When Added during Preincubation(lanes 2 and 3), or 37.5 mg/ml of recombinant SMNwt (lanes 4 and
5) or 37.5 mg/ml of SMNDN27 (lanes 6 and 7). RNA products were The observation that preincubation with SMNDN27 causes
analyzed by electrophoresis. inhibition of splicing, including a block to the first step
(B) In vitro splicing assays after preincubation with SMN wild-type of the pre-mRNA reaction, cleavage at the 59 splice site,
and SMNDN27 recombinant proteins. HeLa cell nuclear extracts and lariat intron formation indicated a block to an earlywere first incubated for 20 min at 308C in the presence of buffer D
step in spliceosome formation. In order to characterize(lanes 2 and 3), or 37.5 mg/ml of SMNwt (lanes 4 and 5) or 37.5 mg/
this block in greater detail and to determine whether theml of SMNDN27 (lanes 6 and 7). The a-32P-labeled chicken
d-crystallin pre-mRNAs were then added and the reactions further snRNPs could interact with the pre-mRNA at all, we
incubated at 308C for the indicated additional times. RNA products analyzed the RNP complexes by native gel electrophore-
were analyzed by electrophoresis. The structures of the splicing sis (Konarska, 1989). As expected, immediately upon
products are shown schematically. addition to a nuclear extract the pre-mRNA rapidly forms
an ATP-independent complex with endogenous RNA-
binding hnRNP proteins termed H complex (Figure 5,
lane 1). With further incubation at 308C in the presence
possibility, we reasoned that such a function may be of ATP, several larger complexes are observed (Figure
revealed if the splicing extract is allowed to run in the 5, lane 2), designated A, B, and C (Figure 8, and see
presence of SMNDN27 before the labeled pre-mRNA Ohno and Shimura, 1996). Interestingly, and consistent
probe is added. We therefore incubated the extract with with the notion that allowing the extract to preincubate
all the components, including an energy-generating sys- under splicing conditions leads to a reduction in active
tem and SMNwt or SMNDN27, but without the pre-mRNA components, the capacity of the extract to form splicing
for 20 min, at which time the probe pre-mRNA was complexes is significantly reduced during a 20 min pre-
added and the reaction was allowed to proceed for an incubation (Figure 5, lane 3). However, SMNwt prevents
additional 20 or 40 min. A strong inhibition of splicing this reduction so that the extract retains and in fact
was observed only in the samples to which the SMND shows increased efficiency of splicing complex forma-
N27 was added during the preincubation period (Figure tion (Figure 5, lane 4). In contrast, although extracts to
4B). Identical amounts of SMNwt and of SMNDN27 were which SMNDN27 has been added show a higher capac-
used in the splicing reactions, and the inhibition by ity to form A and B complexes compared with untreated
the SMNDN27 was concentration-dependent (data not extract, the formation of the C complex, which is the
shown). About 3- to 5-fold mass excess of SMNDN27 mature spliceosome, is completely inhibited (Figure 5,
over endogenous SMN was sufficient for complete inhi- lane 5). These results suggest that SMN has an important
role in maintaining snRNPs in active form and that thebition.
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amino-terminal 27 amino acids of the protein are critical
for this process. Further studies will be needed to define
the composition of the B complex that forms in the
presence of SMNDN27 and to characterize the specific
defect that leads to a block in C complex formation.
Antibodies to the Amino Terminus of SMN Inhibit
and Antibodies to the Carboxyl Terminus
Stimulate pre-mRNA Splicing when
Added during Preincubation
Amino terminal deletions in the SMN gene, or other dom-
inant-negative mutations in SMN, have not been found
so far in SMA patients, who, in the vast majority of cases,
exhibit only dramatic reduction in the level of the wild-
type SMN protein. To mimic this situation more closely,
we sought to address the role of SMN in pre-mRNA
splicing by reducing the available amount of the SMN
protein without addition of an SMN mutant. SMN is
tightly associated with SIP1, this interaction being resis-
tant to dissociation with 1 M NaCl, and is also associated
with other proteins (Liu et al., 1997), thus precluding the
use of immunodepletion as a way of removing exclu-
sively SMN from the extract. We therefore added purified
anti-SMN monoclonal antibody (2B1), to the extract to
ask if this can cause specific immunoinhibition of pre-
mRNA splicing. The results, shown in Figure 6, demon-
strate that 2B1 strongly inhibits splicing but again only
Figure 6. Effect of Preincubation with Anti-SMN Antibodies on Pre-
if added during the preincubation period. The lack of mRNA Splicing In Vitro
inhibition seen when the antibody is added at the same Two micrograms of the purified antibodies Y12 (anti-Sm), 2B1 and
time as the probe pre-mRNA indicates that 2B1 is not exon 7 (anti-SMN), and SP2/0 (control antibody) was incubated in
simply toxic to the reaction (data not shown). Consistent the splicing reaction mixture as described in Figure 5B. a-32P-labeled
chicken d-crystallin pre-mRNA was added and the reactions werewith the dominant-negative effect of SMNDN27, the first
incubated for an additional 20 or 40 min at 308C. RNA products27 amino acids of SMN are part of the epitope recog-
were analyzed by electrophoresis. The schematic structures of thenized by 2B1 (L. P. and G. D., unpublished results). The
RNA products are shown.
specificity of the 2B1 effect is illustrated by the lack of
inhibition by the control antibody SP2/0, and further
by the lack of inhibition of an affinity purified rabbit we did not anticipate that they would produce the same
polyclonal antibody raised against a SMN peptide corre- inhibitory effect seen with SMNDN27, but we wished to
sponding to the extreme C-terminus encoded by exon determine if they could substitute for SMNwt in provid-
7 (Liu et al., 1997). In fact, the anti-exon 7 antibody had ing a stimulatory effect on pre-mRNA splicing when
a strong stimulatory effect. 2B1 is as strong an inhibitor added to extract during preincubation. These experi-
of pre-mRNA splicing as the anti-snRNP antibody Y12 ments were carried out using the adenovirus 2 major
(Figure 6; Padgett et al., 1983). late transcription unit±derived pre-mRNA, Ad-2 DIVS
(Konarska et al., 1984), rather than the d-crystallin pre-
mRNA because we also wished to determine whetherUnlike SMNwt, SMN Mutants Found in SMA
Patients Do Not Stimulate Splicing when the inhibitory effect of SMNDN27 is a general phenome-
non, as opposed to an effect that is unique to d-crystallinAdded during Preincubation
In addition to the homozygous deletion of both telomeric pre-mRNA. Similar to its effect on d-crystallin pre-mRNA
splicing, addition of SMNDN27 during the preincubationSMN genes, several point mutations and partial dele-
tions of the carboxyl terminus of SMN have been identi- time inhibited the splicing of this adenovirus pre-mRNA
(Figure 7). In contrast, wild-type SMN showed a strongfied in SMA patients (reviewed in Burghes, 1997). The
effects of two mutations leading to the severe type I SMA stimulatory effect on mRNA production. Interestingly,
neither SMNY272→C nor SMNDEx7 had any detectablephenotype, the Y272C point mutation and the deletion
of the amino acid sequence encoded by the exon 7 effect, showing neither stimulation nor inhibition of pre-
mRNA splicing. The recombinant proteins used in these(Lefebvre et al., 1995; Burghes, 1997), have been investi-
gated. SMN deleted of exon 7 (SMNDEx7) is also thought experiments were produced side-by-side using the
same procedure, and identical amounts were added toto be the main form produced by the centromeric SMN
gene (Gennarelli et al., 1995). These loss-of-function mu- each assay. All these SMN recombinant proteins were
able to directly bind a GST-SIP1 fusion in vitro, providingtations of SMN are recessive and result in the SMA
phenotype in individuals carrying a deletion of the other further evidence that they were purified in native form
(data not shown). These findings demonstrate that SMNtelomeric SMN allele. As these are recessive mutations
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on nuclear snRNP organization was unexpected. As this
raised the possibility of an involvement of these proteins,
particularly of SMN, in the activity of snRNPs in pre-
mRNA splicing, we examined this directly. Our results
point to a novel function of SMN in the pre-mRNA splic-
ing cycle and suggest that some components of the
spliceosome, likely snRNPs but possibly also other com-
ponents, require SMN for their function. The lack of an
effect of SMNDN27 upon its addition to a splicing extract
indicates that SMN is neither a general inhibitor of splic-
ing nor a splicing factor per se. Rather, inhibition of
splicing by SMNDN27 and by the anti-SMN antibody
2B1 are seen only if they are added to the extract and
the reaction is preincubated before the pre-mRNA probe
is added. This inhibition, which is not observed with
wild-type SMN and which is general rather than pre-
mRNA specific, suggests a role for SMN in regeneration
of snRNPs (and possibly also of other components). It
appears that during the incubation of the nuclear extract
under splicing conditions, including an energy-regener-
ating system, some of its components, likely including
snRNPs, become inactivated and their regeneration to
Figure 7. Effect of SMNwt, SMNDN27, SMNY272→C, and SMNDEx7
functional form requires SMN. Indeed, addition of re-Recombinant Proteins on the In Vitro Splicing of a Different pre-
combinant SMNwt greatly stimulates both spliceosomemRNA
formation and splicing. In splicing competent extracts,Splicing reaction mixture was preincubated with either buffer D (lane
endogenous SMN is sufficient to provide this activity,2) or 20 mg/ml of the indicated recombinant proteins (lanes 3±6) as
described in Figure 4B. a-32P-labeled adenovirus 2 major late pre- but the SMNDN27 causes a block to this regeneration
mRNA (Ad-2 DIVS, lane 1) was then added and incubated for 40 process and acts as a dominant-negative mutant of
min at 308C. The RNA products were analyzed by electrophoresis. SMN because it is able to engage in some of the same
The schematic structures of the RNA products are shown. Note that
interactions as SMN but traps complexes in a nonfunc-the total inihibition of pre-mRNA cleavage by SMNDN27 is not as
tional state. The interactions of SMNDN27 with Sm pro-complete as in Figure 4 because of the lower amount of recombinant
teins, with SIP1, and with SMN are indistinguishableprotein used in this experiment.
from that of wild-type SMN (L. P. et al., unpublished
data). SMN mutations found in SMA patients do not
has an important and unexpected general role in pre- show either a stimulation or an inhibition of splicing,
mRNA splicing, and they provide a direct connection confirming that they represent loss-of-function reces-
between the molecular defect of SMA and the pre-mRNA sive mutants. Since SMNY272→C and SMNDEx7 have
splicing cycle. a highly reduced oligomerization capacity (Lorson et
al., 1998), SMN oligomerization may be required for its
Discussion splicing±regenerating activity. We use the general term
ªregenerationº to describe this function of SMN, as we
We have shown here that SMN has functions both in do not yet know its mechanism. Several recycling fac-
the cytoplasm and in the nucleus in both snRNP biogen- tors that are essential for splicing, mostly DEAD/DEAH
esis and function. Previous experiments in Xenopus oo- box RNA helicases, have been described. Recycling fac-
cytes have demonstrated a role for SIP1 in the biogene- tors, exemplified by S. cerevisiae Prp22 and Prp43, func-
sis of snRNPs by serving as an assembly factor for the tion in the disassembly of snRNPs, splicing factors, in-
snRNAs and the snRNP Sm core proteins (Fischer et tron lariat, and spliced mRNA from the spliceosome
al., 1997). These experiments, however, did not reveal (Staley and Guthrie, 1998). For example, Prp22 is needed
as clear and direct a role for SMN as for SIP1, because for releasing the mRNA from the spliceosome and there-
while microinjections of anti-SIP1 antibodies strongly fore yeast cells that are made deficient in functional
inhibited snRNP assembly, the anti-SMN antibodies had Prp22 accumulate mRNA on spliceosomes in the nu-
a stimulatory effect (Fischer et al., 1997). The experi- cleus but there is no block in pre-mRNA splicing (Com-
ments in somatic cells reported here demonstrate that pany et al., 1991). Similarly, deficiency in Prp43, a recy-
transfection of an SMN mutant blocks snRNP assembly cling factor required for disassembly of U snRNPs-intron
in the cytoplasm, indicating that SMN, like SIP1, is criti- lariat complex, does not result in inhibition of splicing
cal for this process. They further show that the require- (Arenas and Abelson, 1997). Splicing extracts preincu-
ment for SMN in snRNP assembly is a general one and bated with SMNDN27 do not show any cleavage of the
not a phenomenon that is unique to amphibian oocytes. pre-mRNA indicating that even the first step in the splic-
Although the presence of SMN and SIP1 in the nucleus ing reaction, the cleavage at the 59 splice site and the
and their high concentration in gems, adjacent to and concomitant formation of the intron lariat, has not taken
often merged with the snRNP-rich coiled bodies, sug- place. This is somewhat similar to what is seen upon
gested a function for these proteins in the activity of depletion of Prp24, the recycling factor required for re-
annealing of U4 and U6 snRNPs (Raghunathan andsnRNPs in the nucleus, the strong effect of SMNDN27
Spinal Muscular Atrophy and Pre-mRNA Splicing
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Figure 8. A Schematic Model of the Role of
SMN in the pre-mRNA Splicing Cycle
The nuclear function of SMN, and of gems
and coiled bodies, in recycling snRNPs after
pre-mRNA splicing is discussed in the text.
Guthrie, 1998). The RNP gel analysis suggests that there and additional data have raised the possibility that they
have important, albeit not clearly defined, roles in theis a deficiency in functional components that are re-
quired for spliceosome complex C formation. Future formation of both splicing components and the nucleo-
lus (Raska et al., 1990; Lamond and Carmo-Fonseca,experiments will characterize the block to C complex
formation and attempt to define the specific defect that 1993; Bohmann et al., 1995; Roth, 1995; Lamond and
Earnshaw, 1998). The effect of SMNDN27 on coiled bod-results from incubation of the extract with SMNDN27 or
from reduced levels of SMN. We also note that unlike ies provides insight into the function of both gems and
coiled bodies. It indicates that there is a functional rela-recycling factors described so far, SMN and SIP1 do
not contain DEAD/DEAH motifs. However, additional tionship between these two structures and, in particular,
that SMN affects the organization, and likely the func-proteins are found in the SMN/SIP1 complex (Liu et al.,
1997), and it is possible that one of these proteins has tion, of coiled bodies. It is possible that gems and coiled
bodies represent two stations in a pathway along whichsuch an activity.
If this line of thought is correct, then the factors requir- snRNPs need to proceed to become functional. At this
stage, the order of steps between these stations cannoting regeneration, presumably snRNPs, must exist in two
states, inactive and active, and the conversion of inac- be assigned. The observations we describe here more
directly link the functions of coiled bodies and gems totive to active forms requires SMN. The conversion of
active to inactive may be a consequence of their function pre-mRNA splicing components, specifically to a regen-
eration of snRNPs.in splicing or it may be an intrinsic switch that they
undergo independent of splicing. By analogy to the func- The functions we have found for SMN and SIP1 define
them as critical proteins for the generation of the splicingtion of SMN and SIP1 in the cytoplasm, we consider
that snRNPs in the nucleus, although thought of as sta- machinery and thus ultimately for the process of mRNA
biogenesis. Consistent with a housekeeping function forble, fully assembled, and functional RNPs, in fact un-
dergo some disassembly or rearrangements, and SMN SMN, SMN knockout mice display an early embryonic
lethal phenotype (Schrank et al., 1997). Most SMA pa-and SIP1 are required for their reassembly to regenerate
them into functional form. A scheme depicting our cur- tients, particularly those with the fatal infant form, SMA
type I, have a drastic reduction in the amount of SMNrent view of the place of SMN in the pre-mRNA splicing
cycle is shown in Figure 8. The nuclear functions of SIP1 in motor neurons (Lefebvre et al., 1997). In some cases,
SMA patients produce a protein bearing a recessiveare not yet known and are being investigated.
Coiled bodies were first described in 1903 by RamoÂ n mutation like the SMNY272→C and SMNDEx7 analyzed
here. It is therefore important that these mutants do noty Cajal, who observed them in neuronal cells and named
them nucleolar accessory bodies (RamoÂ n y Cajal, 1903). have the capacity to provide the activity of wild-type
SMN in splicing. Together, these findings strongly sug-Over the past several years, coiled bodies have received
much renewed interest as they have been found to con- gest that motor neurons of SMA patients are impaired
in their capacity to produce mRNAs and, as a result,tain the highest concentration of snRNPs in the nucleus,
Cell
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vitro splicing assays in 10 ml were performed essentially as de-become deficient in proteins that are necessary for the
scribed (Ohno and Shimura, 1996) except using half the amount ofgrowth and functions of these cells. We conclude that
HeLa cell nuclear extract (13 mg/ml) in the reaction mixture. ForSMA is a human splicing disease, and better knowledge
preincubation experiments, the splicing mixture was incubated with
of the precise molecular details of the mechanism of the indicated amount of either SMNwt, SMNY272→C, SMNDEx7, or
action of SMN in this process will likely facilitate the SMNDN27 recombinant proteins for 20 min at 308C. Pre-mRNA was
added and the mixture was incubated for a further 20 or 40 min atsearch for a therapeutic approach to this devastating
308C. For antibody inhibition experiments, all antibodies were puri-disease. Finally, although SMA is considered to be an
fied using a protein-G sepharose column (Pharmacia) and dialyzedautosomal recessive disease, the phenoype of SMNDN27
against buffer D (Dignam et al., 1983). Purified antibodies were incu-argues that some mutations in SMN will have a domi-
bated with HeLa cell nuclear extract and 103 SP buffer (Ohno and
nant-negative lethal phenotype. Shimura, 1996) for 20 min at 308C. After addition of labeled pre-
mRNA, the mixture was incubated for an additional 20 or 40 min at
Experimental Procedures 308C. RNA products were analyzed by electrophoresis on a 6%
acrylamide/8.3 M urea gel followed by autoradiography.
Constructs and Recombinant Proteins Production
DNA fragments corresponding to the open reading frames of Analysis of Splicing Complex Formation
SMNwt, SMNY272→C, SMNDEx7, and SMNDN27 were generated by RNP Gel Electrophoresis
by PCR amplification using specific primers. For the transient ex- For analysis of splicing complexes, splicing reactions were carried
pression in HeLa cells the inserts were cloned downstream of the out as described above using a-32P-labeled chicken d-crystallin pre-
CMV promoter into a modified pcDNA3 vector (InVitrogen) con- mRNA. After a 30 min incubation at 308C, 50 mg of heparin (Sigma)
taining the myc-tag sequence corresponding to the epitope recog- were added and the reactions were placed on ice for 10 min. An
nized by the monoclonal antibody 9E10 (Siomi and Dreyfuss, 1995). RNP native gel electrophoresis on a 3.75% polyacrylamide gel was
For the production of purified recombinant proteins, the same performed as described by Konarska (1989).
inserts were cloned into pET28 vector. His6-SMN fusion proteins
were expressed in the E. coli strain BL21(DE3)pLysS and purified Acknowledgments
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